Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) shares saw strong trading volume on Thursday . Wall Street Zen downgraded shares of Forte Biosciences from a “sell” rating to a “strong sell” rating in a report on Saturday, July 25th. According to data from MarketBeat, Forte Biosciences currently has an average rating of “Hold” and an average target price of $72.50. Get Forte Biosciences alerts:Read Our Latest Report on Forte BiosciencesForte Biosciences Trading Down 0.1%The firm has a market cap of $1.07 billion, a price-to-earnings ratio of -16.55 and a beta of 2.62. Featured ArticlesReceive News & Ratings for Forte Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forte Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.